Treace Medical Concepts Reports Third Quarter 2024 Financial Results
Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023 Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted ...
Treace Medical announces limited release of Nanoplasty 3D MIS Bunion Correction
Concepts announced the limited market release of the Nanoplasty 3D Minimally Invasive, MIS, Bunion Correction System and ...
Earnings Preview For Treace Medical Concepts
With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is $6.83, indicating a potential 42.89% upside.
manilatimes1d
Coda Octopus Group Announces Acquisition of Precision Acoustics Limited
Coda Octopus Group, Inc. ("CODA” or the "Company”) (Nasdaq: CODA), a global market leader in 3D/4D/5D/6D imaging sonar ...
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
The Nanoplasty™ MIS System is designed to deliver a reproducible 3D correction of the bunion deformity through a cosmetically appealing, hidden incision on the side of the foot and help patients get ...
More than a third of Brits are wearing ill-fitting shoes and it's risking their health
A study of 2,000 adults found just two thirds have shoes that fit them properly, while 44% of those with ill-fitting shoes ...
More than one in three adults aren’t wearing the right size shoes
MORE than one in three adults aren’t wearing the right size shoes – with some even left in pain as a result. A study of 2,000 adults found just 62 per cent feel their footwear are the ...